Screener
Gilead Sciences GILD Adjustment for Amortization
Adjustment for Amortization at other companies
Other financials
Where this comes from
Reported directly by Gilead Sciences in its filing.
Tagged under the XBRL concept us-gaap:AdjustmentForAmortization.
The source filing: Gilead Sciences’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:13 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000882095-26-000031
| (in millions) | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|
| Net (loss) income | $(8,475) | $3,275 |
| Adjustments to reconcile Net (loss) income to Net cash provided by operating activities: | ||
| Depreciation expense | 191 | 190 |
| Amortization expense | 1,196 | 1,197 |
| Stock-based compensation expense | 449 | 434 |
| Deferred income taxes | (408) | (377) |
| Net (gain) loss from equity securities | (485) | 284 |
| Acquired in-process research and development expenses | 12,150 | 315 |
Item 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FAQ
- What is Gilead Sciences's adjustment for amortization?
- Gilead Sciences (GILD) reported adjustment for amortization of $600M in Q2 2026.
- How has Gilead Sciences's adjustment for amortization changed year-over-year?
- Gilead Sciences's adjustment for amortization increased by 0.3% year-over-year, from $598M to $600M.
- What is the long-term trend for Gilead Sciences's adjustment for amortization?
- Over 4 years (2021 to 2025), Gilead Sciences's adjustment for amortization has grown at a 8.6% compound annual growth rate (CAGR), from $1.72B to $2.39B.
- What does adjustment for amortization mean?
- Adjustment for amortization related to share-based compensation or other operating items.
Ask your AI about Gilead Sciences's adjustment for amortization.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude